Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Non-Hodgkin 1 Influenza, Human 1

Interventions

Cyclophosphamide 21 Cyclosporine 14 fludarabine phosphate 13 Whole-Body Irradiation 13 Peripheral Blood Stem Cell Transplantation 13 Filgrastim 10 Rituximab 9 Mycophenolic Acid 9 Antilymphocyte Serum 9 Radiotherapy 7 Methotrexate 7 Busulfan 7 Melphalan 6 Psychiatric Rehabilitation 5 Etoposide 5 Dexamethasone 5 Cytarabine 5 Aprepitant 5 fludarabine 4 Vincristine 4 Ondansetron 4 Methylprednisolone 4 Granulocyte Colony-Stimulating Factor 4 Doxorubicin 4 Cord Blood Stem Cell Transplantation 4 plerixafor 3 Zidovudine 3 Therapeutics 3 Stem Cell Transplantation 3 Prednisone 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Lymphoma, Non-Hodgkin × influvac × Clear all

NCT01707628 2014-01-31

Rituxivac

St. Antonius Hospital

Phase NA Completed

Influenza, Human, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon ⚡